Ixekizumab successfully treated severe pityriasis rubra pilaris after COVID-19 vaccination.
Skin Health Dis
; : e139, 2022 Jun 16.
Article
in English
| MEDLINE | ID: covidwho-2232649
ABSTRACT
Pityriasis rubra pilaris is an inflammatory dermatologic disorder of unknown cause. We report a 67-year-old man with Pityriasis rubra pilaris might induced by COVID-19 vaccination. The patient developed the lesions after the first dose of vaccine and significantly aggravated after the second dose. He had poor effect and liver function impairment developed after acitretin used, but achieved satisfactory efficacy after replacement to ixekizumab, an interleukin-17A inhibitor.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Case report
Topics:
Vaccines
Language:
English
Journal:
Skin Health Dis
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS